Metabolomics Market Analysis, Geographical Segmentation, Drivers, Challenges, Trends Forecasts Report
The Global Metabolomics Market is expected to reach USD 2,386.4 million, at a CAGR of 14.6%
(firmenpresse) - Metabolomics Market by Product (GC, HPLC, UPLC, NMR, Mass Spectrometry, Surface-based mass analysis, Bioinformatics), Application (Biomarker & Drug Discovery, Nutrigenomics, Toxicology), Indication (Oncology, Cardiology, Inborn Errors) Forecast
The metabolomics market majorly comprises detection techniques such as mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR), and separation techniques such as gas chromatography. These techniques are used in metabolome studies, primarily in toxicology testing and developing personalized medicine.
This research report segments this Metabolomics Market based on product and service, application, indication, and region.
The growing focus on personalized medicine has driven the use of metabolomics tools by manufacturers engaged in developing rigorous strategies for understanding the root of a disease rather than simply treating a patient
Major Market Drivers in Metabolomics Market:
Availability of government and private funding
Increasing pharmaceutical and biotech R&D expenditure
Technological advancements
Growing demand for personalized medicine
Increasing the use of metabolomics in toxicology testing
Key Questions Addressed in the Research Study:
Metabolomics helps identify the type and number of compounds analyzed by making use of several complementary analytical methods and what would be the future of metabolomics instruments in the upcoming years?
How growing demand for personalized medicine and other factors would change the future of the metabolomics market?
Request Research Sample Pages (Metabolomics Market):
https://www.marketsandmarkets.com/requestsampleNew.asp?id=900
Key Market Growth Trend in Metabolomics:
The growing use of hyphenated technologies is likely to provide the largest growth opportunity for metabolomics market players.
Over the past four years, several hyphenated systems have been launched by market players. Hyphenated technology is a combination of two or more analytical tools. Hyphenated technologies reduce cost by requiring the installation of a single instrument. They also provide ease of operation and require lesser space as compared to the installation of two or more standalone devices. In addition, these technologies have broadened the applications of analytical techniques in the analysis of biomaterials, especially natural products.
Growing Demand for Personalized Medicine Drive the Metabolomics Market
The growing focus on personalized medicine has driven the use of metabolomics tools by manufacturers engaged in developing rigorous strategies for understanding the root of a disease rather than simply treating a patient
Major Key Players in Metabolomics Market;
Prominent players in the global metabolomics market are Thermo Fisher Scientific (U.S.), Agilent Technologies (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), and Shimadzu Corporation (Japan). Other leading players in this market include Bio-Rad Laboratories (U.S.), Bruker Corporation (U.S.),
Themen in dieser Pressemitteilung:
metabolomics-market
metabolome
metabolomics
pharmacogenomics
metagenomics
proteomics
drug-discovery
drug-development
marketplace
biopharmaceuticals
molecular-diagnostics
biomaterials
cancer-immunotherapy
market-trends
Unternehmensinformation / Kurzprofil:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 15.05.2019 - 05:19 Uhr
Sprache: Deutsch
News-ID 1549056
Anzahl Zeichen: 3923
contact information:
Contact person: shelly singh
Town:
northbrook
Phone: 18886006441
Kategorie:
Pharmaceuticals & Biotech
Typ of Press Release: Financial
type of sending: send
Date of sending: 15.05.2019
Anmerkungen:
Diese Pressemitteilung wurde bisher 818 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Metabolomics Market Analysis, Geographical Segmentation, Drivers, Challenges, Trends Forecasts Report
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
